Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Han

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Cutis|April 9, 2024
Expanding the Psoriasis Framework: Immunopathogenesis and Treatment UpdatesYvonne Nong, George Han, Jason E Hawkes
Cutis|March 19, 2020
Halobetasol propionate for the management of psoriasisJerry Bagel, Quinn G Thibodeaux, George Han
Cutis|October 22, 2019
Systemic therapies in psoriasis: an update on newly approved and pipeline biologics and oral treatmentsAnnika Havnaer, Jeffrey M Weinberg, George Han
Dermatology and Therapy|April 9, 2021
Epidemiology and Characterization of Atopic Dermatitis in East Asian Populations: A Systematic ReviewJulia Cheng, Jashin J Wu, George Han
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2010
Nitric oxide releasing nanoparticle synthesis and characterizationGeorge Han, Adam J Friedman, Joel M Friedman
Journal of Drugs in Dermatology : JDD|December 2, 2025
More Than Skin Clearance: Connecting Brodalumab's Mechanism of Action to Patient Outcomes in PsoriasisJohn Koo, George Han, Mark Lebwohl, et al.
Endocrinology and Metabolism Clinics of North America|November 30, 2013
Dermatologic manifestations of diabetes mellitus: a reviewBlair Murphy-Chutorian, George Han, Steven R Cohen
Dermatology and Therapy|September 19, 2025
Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic FailureLawrence Green, April Armstrong, George Han, et al.
Cutis|April 19, 2023
New Treatments for Psoriasis: An Update on a Therapeutic FrontierNatalia Pelet Del Toro, Jashin J Wu, George Han
Advances in Therapy|September 23, 2025
IL-17C as a Driver of Inflammation in PsoriasisGeorge Han, April Armstrong, James G Krueger, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Cutis|April 9, 2024
Expanding the Psoriasis Framework: Immunopathogenesis and Treatment UpdatesYvonne Nong, George Han, Jason E Hawkes
Cutis|March 19, 2020
Halobetasol propionate for the management of psoriasisJerry Bagel, Quinn G Thibodeaux, George Han
Cutis|October 22, 2019
Systemic therapies in psoriasis: an update on newly approved and pipeline biologics and oral treatmentsAnnika Havnaer, Jeffrey M Weinberg, George Han
Dermatology and Therapy|April 9, 2021
Epidemiology and Characterization of Atopic Dermatitis in East Asian Populations: A Systematic ReviewJulia Cheng, Jashin J Wu, George Han
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2010
Nitric oxide releasing nanoparticle synthesis and characterizationGeorge Han, Adam J Friedman, Joel M Friedman
Journal of Drugs in Dermatology : JDD|December 2, 2025
More Than Skin Clearance: Connecting Brodalumab's Mechanism of Action to Patient Outcomes in PsoriasisJohn Koo, George Han, Mark Lebwohl, et al.
Endocrinology and Metabolism Clinics of North America|November 30, 2013
Dermatologic manifestations of diabetes mellitus: a reviewBlair Murphy-Chutorian, George Han, Steven R Cohen
Dermatology and Therapy|September 19, 2025
Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic FailureLawrence Green, April Armstrong, George Han, et al.
Cutis|April 19, 2023
New Treatments for Psoriasis: An Update on a Therapeutic FrontierNatalia Pelet Del Toro, Jashin J Wu, George Han
Advances in Therapy|September 23, 2025
IL-17C as a Driver of Inflammation in PsoriasisGeorge Han, April Armstrong, James G Krueger, et al.
Pageof 11